login
login

Europe Daily Bulletin No. 12909

12 March 2022
Contents Publication in full By article 25 / 28
EU RESPONSE TO COVID-19 / Health
Covid-19, Valneva says it is confident in evaluation of its vaccine, but announces delay in delivery of doses to Member States
11/03/2022 (Agence Europe)

Valneva SE says it expects a positive recommendation from the European Medicines Agency for its adjuvanted inactivated whole virus Covid-19 vaccine for adults aged 18-55 by April 2022.

The company reported on Friday 11 March that its SARS-CoV-2 vaccine candidate (VLA2001) is still under review by the European Medicines Agency’s Committee for Medicinal Products for Human Use, with a review date of 2 December 2021.

The EMA will need to be satisfied with the ongoing review of the vaccine...

Contents

VERSAILLES SUMMIT
Russian invasion of Ukraine
EXTERNAL ACTION
SECTORAL POLICIES
ECONOMY - FINANCE - BUSINESS
EUROPEAN PARLIAMENT PLENARY
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
EU RESPONSE TO COVID-19
NEWS BRIEFS